Literature DB >> 31197491

CDI cross-linked β-cyclodextrin nanosponges of paliperidone: synthesis and physicochemical characterization.

Atul P Sherje1, Anushree Surve2, Pravin Shende3.   

Abstract

Paliperidone (PLP) is an antipsychotic drug indicated for treatment and management of schizophrenia. The current study demonstrates potential of PLP-loaded β-cyclodextrin-based nanosponges (CDNS) for solubility enhancement and prolonged release of PLP. The inclusion complexes of PLP with carbonyldiimidazole (CDI) cross-linked nanosponges were synthesized. The drug-loaded CDNS were characterized for particle size, zeta potential, encapsulation efficiency, stability study, in vitro drug release studies. The interaction of PLP with CDNS was ascertained by FTIR, DSC and PXRD studies. The particle size and zeta potential values were sufficient to obtain stable formulations. Solubility was significantly increased and in vitro drug release studies revealed prolonged release of PLP from the CDNS for 6 h. PXRD study revealed that the crystallinity of PLP was decreased due to complexation with the CDNS. Thus, cyclodextrin-based nanosponges represent a novel approach for solubility enhancement and improved dissolution of selected model drug PLP.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31197491     DOI: 10.1007/s10856-019-6268-0

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  13 in total

Review 1.  Cyclodextrin-based nanosponges: A critical review.

Authors:  Atul P Sherje; Bhushan R Dravyakar; Darshana Kadam; Mrunal Jadhav
Journal:  Carbohydr Polym       Date:  2017-05-26       Impact factor: 9.381

2.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

Authors:  H Y Meltzer; S Matsubara; J C Lee
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

3.  Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats.

Authors:  Magdalena Kozielska; Martin Johnson; Venkatesh Pilla Reddy; An Vermeulen; Cheryl Li; Sarah Grimwood; Rik de Greef; Geny M M Groothuis; Meindert Danhof; Johannes H Proost
Journal:  Pharm Res       Date:  2012-03-22       Impact factor: 4.200

4.  Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formulations.

Authors:  Pravin Shende; Yogesh A Kulkarni; R S Gaud; Kiran Deshmukh; Roberta Cavalli; Francesco Trotta; Fabrizio Caldera
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

5.  Self-association and cyclodextrin solubilization of drugs.

Authors:  Thorsteinn Loftsson; Auethur Magnúsdóttir; Már Másson; Jóhanna F Sigurjónsdóttir
Journal:  J Pharm Sci       Date:  2002-11       Impact factor: 3.534

Review 6.  Recent advances in cyclodextrin delivery techniques.

Authors:  Hidetoshi Arima; Yuya Hayashi; Taishi Higashi; Keiichi Motoyama
Journal:  Expert Opin Drug Deliv       Date:  2015-06-22       Impact factor: 6.648

7.  Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.

Authors:  Atul Sherje; Vaishali Londhe
Journal:  Curr Drug Discov Technol       Date:  2014

Review 8.  Evolution of Cyclodextrin Nanosponges.

Authors:  Fabrizio Caldera; Maria Tannous; Roberta Cavalli; Marco Zanetti; Francesco Trotta
Journal:  Int J Pharm       Date:  2017-06-20       Impact factor: 5.875

Review 9.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.

Authors:  Jacob N Lockhart; David M Stevens; Dain B Beezer; Ariel Kravitz; Eva Harth
Journal:  J Control Release       Date:  2015-09-03       Impact factor: 9.776

View more
  5 in total

Review 1.  History of Cyclodextrin Nanosponges.

Authors:  Ilona Krabicová; Silvia Lucia Appleton; Maria Tannous; Gjylije Hoti; Fabrizio Caldera; Alberto Rubin Pedrazzo; Claudio Cecone; Roberta Cavalli; Francesco Trotta
Journal:  Polymers (Basel)       Date:  2020-05-14       Impact factor: 4.329

2.  Cyclodextrin-based host-guest complexes loaded with regorafenib for colorectal cancer treatment.

Authors:  Hongzhen Bai; Jianwei Wang; Chi Uyen Phan; Qi Chen; Xiurong Hu; Guoqiang Shao; Jun Zhou; Lihua Lai; Guping Tang
Journal:  Nat Commun       Date:  2021-02-03       Impact factor: 14.919

Review 3.  Nutraceutical Concepts and Dextrin-Based Delivery Systems.

Authors:  Gjylije Hoti; Adrián Matencio; Alberto Rubin Pedrazzo; Claudio Cecone; Silvia Lucia Appleton; Yousef Khazaei Monfared; Fabrizio Caldera; Francesco Trotta
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

Review 4.  Cyclodextrin-Based Nanosponges: Overview and Opportunities.

Authors:  Gianluca Utzeri; Pedro M C Matias; Dina Murtinho; Artur J M Valente
Journal:  Front Chem       Date:  2022-03-24       Impact factor: 5.221

Review 5.  Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D2-Serotonin 5-HT1A Heteromers.

Authors:  Sylwia Łukasiewicz
Journal:  Polymers (Basel)       Date:  2021-03-24       Impact factor: 4.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.